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per cent protein hydrolysate, vitamins, sodium, 
potassium, magnesium, and chloride. Adult pa-
tients are gradually brought up to 24 hour 
volumes of 5 liters infused through meticulously 
cared for, central venous catheters. Once again, 
attention to detail and reliance on fundamental 
principles win the day in surgical care. This sort 
TRANSPLANTATION 
of approach to the preparation of high risk pa-
tients for operation and monitoring methods will 
prevent shock or lead to its early recognition. 
There have been no dramatic breakthroughs in 
the study of shock and metabolism during the 
past year, but steady progress of this kind will re-
sult in the saving of many lives. 
THOMAS E. STARZL, M.D., F.A.C.S., Denver, Colorado 
THERE IS a widespread interest in the experi-
mental and clinical problems inherent in the 
transplantation of tissues and organs. There is a 
pervading spirit of optimism about the practical 
use of grafting procedures tempered by a realiza-
tion of their imperfections. 
PRESERVATION 
There is no way that widespread and efficient 
utilization of organ homografts will ever be 
possible without major new developments in 
organ preservation which will allow banking for 
weeks or months. With the vital organs, the 
progress in this direction has been minor; 
almost all the investigations have been found to 
be concerned either with short range conserva-
tion or else with the pathophysiology of ischemic 
damage. 
Kidney. Brodman has shown a self-perpetuat-
ing effect of ischemia in rab bi t kidneys caused by 
an intermittent holdup of blood flow at the ef-
ferent arterioles at some time after initially 
satisfactory revascularization. Under similar ex-
perimental conditions, Nanninga demonstrated 
a protective (jffect of ethacrynic acid and furo-
semide upon rat kidneys, provided that the drugs 
were administered at the beginning of the inter-
val of vascular cross clamping. The reason for the 
benefit is not clear. 
McCullough, Jacobs, and Halasz described 
kidney preservation, perfusing a fluorocarbon in 
a cold salt solution emulsion at low flow rates. 
Fluorocarbon is a chemically inert liquid which 
allows for the exchange of carbon dioxide and 
oxygen but not of other metabolites. Canine 
kidney au tografts could be kept viable for as 
long as 24 hours. 
An argument for simplicity of short term pres-
ervation was contained in the results of another 
canine study by Martin. He found that kidney 
autografts which were protected by surface cool-
ing alone remained in good condition for as long 
as eight hours after nephrectomy. In clinical 
practice, this should be sufficien t time to find a 
recipient on the basis of histocompatibility 
matching and even to fly a renal homograft from 
one city to another. 
Heart. Two studies with excised canine hearts 
are of in terest because of the similarity of results, 
despite different experimental conditions. Mc-
Cord removed the hearts and made no attempt 
whatever to protect the anoxic organs, whereas 
Lande used relatively sophisticated perfusion 
with oxygenated blood. Under both circum-
stances, the decay of quality of the hearts be-
came pronounced after about two hours. As the 
organs became unacceptable, oxygen consump-
tion fell. Perhaps the results highlight the in-
adequacies of presently available means of sup-
porting the artificial circulation of single or-
gans. 
Skin. Some of the most interesting observa-
tions on preservation have been made by Abbott, 
who tested freeze-dried skin in mice for its 
ability to sensitize recipients to subsequent, 
similarly processed grafts or to fresh tissue from 
the same donor strain. There was no loss of anti-
genicity with freezing alone, but after freezing 
and lyophilization, histocompatibility anti-
gens could no longer be identified or could 
second set reactions be induced. At a practical 
level, the clinical implication is that this kind of 
biologic dressing can be used wi thou t the danger 
of recipient sensitization. 
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THE DIAGNOSIS OF REJECTION 
Efforts to sharpen the criteria of diagnosis of 
homograft rejection are still being made, even 
with the kidney. Andrews, Coppola, and Ville-
gas re-examined urinary and serum concentra-
tions of lactic dehydrogenase and one of its iso-
enzymes, alpha hydroxybutyric dehydrogenase, 
as indexes of either physical or immunologic in-
jury to renal homografts or autografts. With 
kidney damage, there were elevations with both 
measures, but the organ specificity was greater 
with the isoenzyme. 
In an exhaustive investigation, Graham and 
Lower and their associates examined the inci-
dence, severity, and laboratory findings of 
cardiac rejection in dogs being treated with 
azathioprine to which methylprednisolone or 
homograft irradiation were intermittently added. 
There were 39 dogs which lived from nine to 422 
days after heart replacement. These 39 recipients 
had 59 episodes of rejection, approximately a 
fourth of which were promptly fatal. In the others, 
rejection was at least partially, and often com-
pletely, reversible by intensification of-immuno-
suppressive treatment. A number of serum en-
zyme determina nons were evaluated as diagnostic 
aids. None of these tests was particularly help-
ful, and the best diagnostic indexes were pro-
vided by clinical observation and electrocar-
diography. 
After liver transplantation in human beings, 
sepsis of the homografts has been reported. 
Alican and Hardy showed in their study of 
autografts that this complication should not 
arbitrarily be ascribed to rejection, since hepatic 
abscesses and cholangitis were seen in their ex-
perimen ts in the absence of an immunologic 
barrier. However, their studies did not disprove 
that rejection could not contribute to this kind of 
infectious problem. 
A decline in blood flow is apparently a 
characteristic feature of all rejecting homografts. 
This principle was confirmed by Rosen and his 
associates who transplanted canine larynges to 
unmodified recipients. With the onset of rejec-
tion, or sometimes preceding it, flow declines 
Were described with a krypton washout tech-
nique. 
HUMORAL ANTIBODIES AND REJECTION 
The classical view of rej ection has been tha t 
the destructive agents are mononuclear cells and 
that there is little participation of humoral anti-
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bodies. In recen t years, there has been a growing 
appreciation that circulating immunoglobulins 
may play an important ancillary role in rejec-
tion or, under certain circumstances, that they 
may be the most important element in the in-
duction of injury to the transplant. 
Cochrum and Kountz examined the sera of 
24 human recipients of renal homo grafts at 
various times after transplantation. The sera 
from patients who did not have overt rejection 
did not develop easily detectable antibodies. 
However, in 11 of the patients whqse kidneys 
underwent clinically diagnosed rejection, cyto-
toxic antibodies were regularly found. Two of 
these homografts were ultimately removed and 
shown by immunofluorescent studies to contain 
immunoglobin G, immunoglobin M, and beta 
IC complement. Antibodies eluted from the 
kidney specimens contained the same cytotoxins 
as had previously been present in the sera. It is 
conceivable that the humoral antibodies origi-
nated from the same sensitized lymphoid cells 
that were responsible for classical rejection. The 
work of Irvin supported the concept that the 
division of immunity into cell-mediated and 
humoral varieties may be artificial. 
When cytotoxic antibodies are present in a 
recipient prior to transplantation, there is an in-
creased risk that the homograft may undergo 
immediate destruction. Robertshaw and Hume 
and their associates studied this problem in dogs 
by immunizing animals with the skin and other 
tissue of an organ donor. The donor kidney was 
then removed, exposed briefly to serum from the 
hyperimmunized dog, and then returned back to 
the original host in which it promptly underwen t 
cortical necrosis. The observations provided fur-
ther evidence of the nonspecificity of the de-
structive process of hyperacute rejection, at 
least in the sense that the end stages of this pro-
cess were served by elements within the autol-
ogous circula tion after the stage had been set by 
initial exposure to homologous antibodies. 
ANTILYMPHOCYTE SERUM 
Of all the immunosuppressive agents, the one 
that received the greatest attention was heter-
ologous antilymphocyte serum. 
Preparation. Antilymphocyte serum is, in no 
sense, a standardized product like azathio-
prine or prednisone. Moreover, its mechanism of 
action is not known, although there has been in-
creasing acceptance that these antisera selec-
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tively destroy long-lived circulating lympho-
cytes of thymic origin. The results of a tissue 
culture study by Lundgren with the lympho-
cytes of renal homograft recipients were in ter-
preted as evidence against this particular hy-
pothesis. 
If antilymphocyte sera act by destroying 
special populations of lymphocytes, it might be 
anticipated that the use of different lymphoid 
antigens for immunization could influence the 
activity of the end-product. Miller and Cohn 
examined this possibility in mice, using the rab-
bit as a heterologous serum donor. As a first 
step, they compared the ability of antithymo-
cyte and antilymph node lymphocyte serum to 
slow the first set rejection of mouse skin grafts. 
The degree of protection was identical. How-
ever, under special recipient conditions which 
included near total body irradiation or prior in-
duction of sensitivity to donor strain tissues, they 
obtained data supporting the idea that antisera 
could be raised against specific populations of 
lymphocytes. 
Means to study this question further may have 
been provided by investigations on noncellular 
thymic extracts. Quint, Hardy, and Monaco 
administered thymosin to mice which were also 
given rabbit antimouse-lymphocyte serum. Pro-
vided that the thymosin was given in advance, 
it potentiated the immunosuppressive effect of 
the antiserum. I t was speculated that the thymo-
sin acted by mobilizing thymus-dependent cir-
culating lymphocytes which were thereby 
rendered more susceptible to the antilympho-
cyte serum. 
Davis, Cooperband, and Mannick worked 
with a soluble material obtained from human 
thymic tissue that had almost the opposite 
properties of thymosin in that this substance was 
an inhibitor rather than an augmentor of 
lymphocyte proliferation in tissue culture. In 
view of this action, it might be predicted that the 
humoral factor of Davis would not be synergistic 
with, and might even cancel, the antirejection 
potency of antilymphocyte serum. 
Standardkation. To date, there is no totally re-
liable in vitro test for assessing the immunosup-
pressive potency of antilymphocyte sera. The 
technique described by Clayman determines the 
ability of antihuman serum to prevent rejection 
of monkey-to-monkey homografts. The method 
reported by Saleh, Gordon, and MacLean 
grades the quality of sera according to the sup-
pression of graft versus host reactions induced by 
injecting lymphocytes beneath the capsule of the 
rat kidney. 
Refinement. Two methods have been described 
for removing purified globulin from raw anti-
sera. Alexander used a standard diethylamino-
ethanol sephadex technique, while Moberg used 
an electrophoretic separator of such efficiency 
that it could process a liter of raw serum per 
hour. 
Toxicity. The most specific risk of chronic 
therapy with heterologous serum or globulin is 
sensitization to the injected foreign protein. 
Gewurz and his associates showed that tolerance 
to horse globulin could often be accidentally 
produced in patients during a course of intra-
venous treatment with antilymphocyte globulin. 
However, Anderson and Wood warn about the 
repeated intravascular infusion of high potency 
antilymphocyte serum, since thrombosis and 
vasculitis could be produced locally. In addition, 
intravascular coagulation was also produced in 
distant organs including the lung. 
. Reports by Wanebo, Zipp, and Kountz and 
by Mandel and DeCosse show that both trans-
planted and spontaneously occurring lym-
phomas in mice had an accelerated growth rate 
under the influence of antilymphoid sera. This 
effect is thought by Mandel and DeCosse to be. 
the consequence of potent immllnosuppression, 
rather than to be a specific risk-from the anti-
sera. This point of view was upheld by Penn who 
reported that only about one out of every seven 
patients in whom new malignant growths de-
veloped after renal homo transplantations, had 
received prior treatment with antilymphocyte 
globulin. 
OTHER IMMUNOSUPPRESSIVE MEASURES 
Mechanical lymphocyte depletion. By means of 
thoracic duct drainage, Fish and his associ-
ates removed th~ lymphocytes of six calves and 
11 patients. Profound lymphopenia was pro-
duced but not hypogammaglobulinemia. In the 
calves, renal homograft survival was prolonged, 
providing the lymphocyte depletion was carried 
out in advance. The thoracic duct fistulas in the 
patients were introduced before kidney trans-
plantation from cadaveric donors and remained 
open for ten to 123 days. In the human recipi-
ents, early rejection tended to be both late and 
mild. Pharmacologic means of immunosuppres-
sion were withheld for 19 to 50 days. After this 
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time, maintenance doses of azathioprine and 
prednisone were begun. 
Local homograft irradiation. With as much as 
1,500 rads, McCredie, Inch, and Sutherland 
irradiated skin transplants on the backs of mice 
with prolongation of graft survival. When this 
total dose was given to the four extremities, the 
same effect was obtained, suggesting that the 
irradiation effect was systemic rather than a 
local one. 
Drugs. Thiocymetin® (thiamphenicol), an 
analogue of Chloromycetin® (chlorampheni-
col), was evaluated by Linehan and his associates 
for its ability to slow the rejection of canine renal 
homografts. The dogs lived for an average of 21 
days compared with nine days for the untreated 
controls. Phytohemagglutinin, an extract of the 
Phaseolus vulgaris bean which causes lymphocyte 
blast transformation, was found by Gertner to 
have almost no protective effect upon canine skin 
homografts. However, it seemed to add to the 
immunosuppression of azathioprine and also of 
prednisone but not to that of antilymphocyte 
serum. 
Macdonald has studied the value of medroxy-
progesterone as a substitution for prednisone 
in a treatment protocol for canine kidney recipi-
ents that also included azathioprine. Survival 
using medroxyprogesterone was superior to that 
with prednisone. The addition of antilympho-
cyte serum as a third agent did not confer addi-
tional benefit. 
Any clinical trials with medroxyprogesterone 
as a substitute for prednisone will be awaited 
with great interest because of the excessive mor-
bidity rate that has followed the use of high 
dose prednisone therapy in kidney transplant 
recipients. CrutchIow and Bright emphasized 
the profound changes in bone metabolism or 
structure that can be induced with chronic 
prednisone administration. In a badly needed 
study, Fisher and Bickel showed how steroid 
treatment in rabbits could cause increases in 
serum lipids with the formation of fat emboli 
that passed to terminal arterioles of bone and 
caused both osteoporosis and osteonecrosis. 
In a different approach, Murphy attempted 
to increase the safety with which large doses of 
azathioprine could be given by concomitantly 
administering a yeast extract that has been said 
to prevent the bone marrow toxicity of nitrogen 
mustard. The azathioprine seemed to be better 
tolerated and to cause less marrow depression. 
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GRAFT ACCEPTANCE 
As reillustrated by the canine study of Shan-
field, a homograft may come to be more or 
less well tolerated in its new host and, in some 
instances, may continue to function chronically, 
even though all immunosuppression is stopped. 
There may be more than one explanation for 
the privileged status. 
Tolerance. The term tolerance has been used 
to indicate a selective loss of host responsiveness 
to specific antigens with retention of otherwise 
normal immunologic reactivity. Within the lim-
its of this definition, experiments of Graff and 
Newton were interpreted as showing a relation 
between sensitization and tolerance that de-
pended upon the dose of sensitizing antigen and 
the strength of the histocompatibility barrier. 
Enhancement. Evidence was presented by Raju 
and Grogan, Yussman and Hines, Holl-Allen 
and his associates, and Stuart and his associa tes 
that specific immunologic tolerance was not the 
full explanation for graft acceptance. In the 
experiments of Stuart, renal homotransplanta-
tion was performed in rats across a strong histo-
compatibility barrier without the aid of immu-
nosuppressive agents. The recipients were condi-
tioned before operation by the intravenous ad-
ministration of donor genotype spleen cells as 
well as by the injection of specific antidonor 
serum. The kidney homografts survived for as 
long as 18 months, in spite of the fact that the 
recipients sometimes did not have a loss of 
immunologic memory for the donor strain tis-
sues. Stuart suggests that both tolerance and 
enhancement were factors in the graft pro-
tection. 
Other factors. The possibility exists that por-
tions of grafted tissues may eventually assume 
the genetic characteristics of the recipient. 
Williams and Alvarez report a technique by 
which the sex of vascular endothelium of trans-
planted kidneys could be studied. Their pre-
liminary results suggest that a sex change of 
arterial endothelial cells might occur, a finding 
that was not confirmed by Kashiwagi in the 
hepatic arteries of human liver homografts. 
However! Kashiwagi did note that the Kupffer 
cells of hepa tic transplants became of host origin 
at all times after three months. 
HISTOCOMP A TIBILITY MEASUREMENT 
The advantages and especially the limitations 
of histocompa tibility typing wi th serologic meth-
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ods have been described by Terasaki in relation 
to cardiac transplan ta tion. A more cumbersome 
and time-consuming but potentially more dis-
criminating technique for matching donors and 
recipien ts is the mLxed lymphocyte culture test. 
The latter method was evaluated in untreated 
dogs by Sullivan who found consistently longer 
survival with good compatibility. 
GRAFT FUNCTION 
A number of problems have been raised con-
cerning the function of various transplanted 
organs and the effects upon these grafts of de-
nerva tion, blood supply, and other factors. 
Limbs. In puppies, Furnas showed that reim-
planted right forelimbs almost never provided 
normal subsequent function but that most pup-
pies were eventually able to use the leg for 
auxiliary support. 
Spleen. Kelly, Pechet, and Eiseman demon-
strated that perfused porcine spleens in an extra-
corporeal system synthesized antihemophiliac 
globulin and at a level that supported the con-
cept of splenic transplantation for the treatment 
of hemophilia. 
Liver. Investigations by Lee and by Sawada 
appear to reaffirm the desirability of perfusing 
the portal system of liver homografts with venous 
blood from the splanchnic bed. Even with this 
advantage, Sawada usually observed atrophy if 
the hepatic transplants were used as auxiliary 
organs in dogs. The shrinkage was apparently 
due to the combined adverse effects of rejection 
plus competition of the transplanted liver with 
the host's own organ. Bell also pointed out that 
not all the injury of liver homografts can be 
attributed to rejection. He studied the cholestasis 
that can be caused by the immunosuppressive 
agent, azathioprine. This finding was minimized 
in the dogs of his study by the administration of 
choleretic agents. 
As confirmed by the studies of Giles and 
Slapak, one of the most interesting features of 
liver transplantation is that the homograft can 
syn thesize protein of a new type. This is not sur-
prising with those proteins that are normally 
produced by hepatocytes. Since the immune 
globulins are thought to be produced extra-
hepatically, Kashiwagi added a further dimen-
sion by showing that new gamma G globulin 
phenotypes were conferred upon human recipi-
ents of orthotopic livers. Some of these livers 
were eventually studied at autopsy and were 
shown to contain lymphoid tissue. Presumably, 
these lymphoid deposits had been accidentally 
transplanted along with the liver, had remained 
viable, and had synthesized and released the 
new gamma G globulin for long periods. 
Lungs. Graf, Nadel, and Edmunds found that 
by two to six months, pulmonary autografts 
had regeneration of the efferent autonomic 
nerves. The afferent autonomic nerve conduc-
tion had not returned and, consequently, the 
animals did not have Hering-Breuer or cough 
reflexes. 
Richards determined that the function of five 
pulmonary autografts and one homograft was 
not normal eight to 12 months postoperatively. 
However, the high vascular resistance, low pul-
monary blood flow, and low oxygen uptake 
could all be partly reversed when the contra-
la teral normal lung was exposed to pure ni tro-
gen. Thus, the impairment of the grafted lungs 
was partly a reflection of the functional inter-
relationship with the contralateral lungs rather 
than an indicator of a serious intrinsic deficiency. 
HETEROTRANSPLANTATION 
When tissues and organs are transplanted 
across a species bamer, this is designated hetero-
transplantation or xenotransplantation. The 
terms are descriptive but imprecise, since the 
kind of rejection that may follow may be no 
more severe than after many homotransplanta-
tions. On the other hand, a xenograft may be 
repudiated within a matter of minutes, depend-
ing upon the kind of donor-recipient animal 
combinations. If hyperacute rejection occurs, it 
can usually be shown that preformed heterospe-
cific antibodies are present in the recipient and 
that these have a high avidity for cells of the 
donor species. 
Cerilli and· Gideon studied relatively easy 
heterotransplantations from rats or hamsters to 
mice. The skin grafts were repudiated by un-
modified recipients after an average of 5.8 and 
4.5 days, respectively, long enough to conclude 
that the rejections were chiefly by cell-mediated 
immunity. Treatment with antilymphocyte 
serum significantly. prolonged skin survival. The 
addition of procarbazine hydrochloride to anti-
lymphocyte serum was even more effective. 
Gunnarsson and his associa tes used a more 
difficult system, transplanting porcine kidneys to 
goats. Kidney survival in untreated recipients 
was about one day, an indication of destruction 
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by preformed heterospecific antibodies. The 
survival time was extended to two days by the 
administration of cytosine arabinoside, an agent 
which is said to suppress humoral antibody re-
sponse. With the use of antilymphocyte globulin, 
the period of viability was seven days. When 
antilymphocyte globulin and cytosine arabi-
noside were used together, the organs were not 
rejected until 14 days. These results are the best 
that have yet been reported with whole organ 
transplantation using such a difficult species 
combina tion. 
Rabbit to dog renal heterotransplantation re-
sults in violent repudiation of the kidneys within 
six to 12 minutes. Ellis and his associates were 
able to slow this process as much as ten times by 
pretreating the kidneys with a collagen emulsion 
prepared from calf skin. They concluded that 
the protective effect was by coating of the vessels 
and glomeruli, thereby preventing an antibody 
attack on the vascular endothelium and secon-
darily avoiding platelet aggregation. 
Cross circulation of patients with baboons was 
recently reported for the treatment of hepatic 
insufficiency. Gayle, Williams, and Hume de-
scribed the consequent lethal effects upon the 
animals and suggested that they had died from 
heterograft rejection. There was evidence that 
the baboons absorbed antibodies present in 
human beings. In some tissues, such as the lung, 
there were morphologic findings suggestive of a 
hyperacute rejection. 
SURGICAL TECHNIQUE 
Benzing and his associates performed ortho-
topic cardiac transplantation in dogs with the 
Shumway-Lower technique, except that a 
Teflon® (polytetrafluoroethylene) coupler was 
used to reconnect the aorta and pulmonary 
artery. The ischemia time was lowered, and the 
annoying hemorrhage encountered in suturing 
the canine aorta was eliminated. 
Dwoskin, Soderdahl, Purtilo, and Harrison 
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tested new methods of ureteroneocystostomy 
after canine renal transplantation, bringing the 
homograft ureter through the distal portion of 
the recipient's own ureter in two ways. Neither 
method yielded satisfactory results, and these 
investigators did not recommend these technical 
modifica tions for clinical trial. 
CLINICAL NOTES 
There are highly significant, purely clinical 
reports on extrarenal organs that deserve more 
than passing notice. For example, Kelly and 
Lillehei and their associates, after encountering 
many difficulties in their early trials, have now 
been able to discharge two patients from the 
hospi tal after combined pancrea tic and renal 
transplantation. The longest follow-up period 
in those patients still living is now five months. 
The insulin requirements in these brittle dia-
betic patients has been minimal or absent. 
Steady progress has been recorded with liver 
transplantation. In six instances, there has been 
survival of a year or more, the longest living 
pa tien t has now survived for a period of20 mon ths. 
Several of the late deaths after liver transplan-
tation have been in patients in whom the orig-
inal disease was hepatoma and who ultimately 
died of metastases. Consequently, the prime 
indication for liver transplantation in the future 
will certainly be for benign diseases, such as .bil-
iary atresia and cirrhosis. 
Between six and ten patients with cardiac 
disease have lived for a year or more after car-
diac transplantation, the longest survival period 
being 17 months. The autopsy findings in a 
patient after 19 postoperative months have been 
reported. In essence, the transplanted heart, 
which eventually failed, was small and contained 
minor interstitial fibrosis and few mononuclear 
cells. The major finding was acquired oblitera-
tive disease of the coronary arteries, such as that 
reported in the past in canine cardiac trans-
plants by Lower and Shumway. 
